Indian Drug Makers Seek Relief From Price Control
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Even as drug pricing in India reaches a flashpoint between the domestic pharmaceutical industry and the government, a high-level meeting has been convened next week between the industry, the ministry of chemicals and fertilizers and the National Pharmaceutical Pricing Authority, the body that determines and regulates pricing of drugs, to chart out some remedial measures for drug makers who are currently grappling with a significant escalation in production costs
You may also be interested in...
Pressure Rises To Pass India’s Draft Drug Policy
NEW DELHI - Indian Chemicals Minister Ram Vilas Paswan is making an all out effort to get the country's draft pharmaceutical policy cleared by the Group of Ministers in its next meeting
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).